Media release 5 March 2019 | A 12 month pilot programme testing for bladder cancer is achieving positive results for the Counties Manukau region.
The Cx Bladder test is a non-invasive molecular based urine test for possible bladder cancer in patients’ presenting with blood in the urine (haematuria).
“Patients who have been referred by their GP and who meet the Cx bladder criteria for testing are sent an information pack and information about the laboratories that hold the relevant test kit,” says Counties Manukau Service Manager Elective and Urology Services, Sue Shipperlee.
“They can go to a laboratory close to home or work to do their tests rather than having to come into a clinic for an appointment.
“The tests are then processed and reviewed with the patient and GP being informed about the results and whether they are normal or need further investigation.”
So far, nearly 200 samples have been tested since the pilot began in October, 2018, with around 80 of the 200, needing further investigation.
“The majority of these tests for bladder cancer showed no major issues meaning patients did not have to undergo a more invasive procedure and could be discharged back to community or, for some, have follow-up for other conditions where further investigation was warranted,” says Ms Shipperlee.
“One of the great things about the programme is the test is non-invasive and therefore more comfortable for the patient, it cuts down waiting times and the results usually take one to two weeks for an outcome.”
A full review will be carried out at the end of the pilot.
Issued by: Counties Manukau Health Communications
Media Line: 09 250 9857 Email: Communications@middlemore.co.nz